je.st
news
Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase...
2014-11-15 20:32:22| Biotech - Topix.net
Keryx Biopharmaceuticals, Inc. today announced results from a 48-week Open Label Extension safety study in which Ferric Citrate demonstrated long-term safety and efficacy in dialysis-dependent chronic kidney disease patients with elevated serum phosphorus levels, or hyperphosphatemia. The OLE findings were presented as a late-breaking poster at the 2014 American Society of Nephrology's Kidney Week meeting in Philadelphia, PA.
Tags: results
phase
announces
citrate
Category:Biotechnology and Pharmaceuticals